Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-06

Clinical Trial Update: Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing brimonidine and timolol ophthalmic solution with latanoprost versus latanoprost alone in glaucoma patients was terminated, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine and Timolol Ophthalmic Solution With Latanoprost
  • Latanoprost (Latanoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Angle-Closure | Phase 4 | Status: TERMINATED | Results posted: 2013-02-06